PRDM9 and metabolic dysfunction-associated steatotic liver disease: Our results identified histone methyltransferase G9a as a potential downstream effector of mTORC1 that is involved in the repression of key genes of the autophagy process under lipotoxic conditions such as NAFLD (Fig. 7).